BIO-TECHNE Corp 8-K

What Happened
Bio‑Techne Corporation (TECH) filed a Form 8‑K on May 6, 2026 attaching a press release that announced the company’s results of operations for the quarter and nine months ended March 31, 2026 and its financial condition as of March 31, 2026. The filing also includes a press release announcing a cash dividend. The 8‑K was signed by Shane V. Bohnen, Senior Vice President, General Counsel and Secretary.

Key Details

• Filing date: May 6, 2026; reporting periods: quarter and nine months ended March 31, 2026.
• Exhibits: Press release with results (Exhibit 99.1) and press release announcing a cash dividend (Exhibit 99.2).
• The filing notes the attached information is furnished (not “filed”) for purposes of Section 18 of the Exchange Act.
• Signature: /s/ Shane V. Bohnen (SVP, General Counsel & Secretary).

Why It Matters
This 8‑K signals that BIO‑TECHNE has publicly released its latest quarterly financial and operational results and declared a cash dividend—items that can affect short‑term stock performance and income-focused investors. Retail investors should read the attached press releases to see specific earnings, revenue, cash‑flow and dividend amount/timing, since the Form 8‑K itself references those exhibits rather than repeating financial line items.